Navigation Links
Full Agenda Announced for CMAC 2011 - CBI'S 2nd Annual Commercialization and Market Access Congress
Date:10/18/2011

WOBURN, Mass., Oct. 18, 2011 /PRNewswire/ -- CBI is pleased to announce the full agenda for CMAC 2011 - CBI's 2nd Annual Commercialization and Market Access Congress, being held December 6-7, 2011 in Philadelphia, PA. The program, sponsored by Campbell Alliance and McKesson Specialty Care Solutions, delivers pre- and post-launch strategies, dynamic programming and extensive coverage of market access trends.

Anchored by conference chairman, Robert Besthof, Vice President, Commercial Lead, ERP U.S. & Puerto Rico, Pfizer Inc., CMAC 2011 boasts an impressive speaker lineup from AstraZeneca, Baxter, Bristol-Myers Squibb, Daiichi Sankyo, Endo, Eli Lilly, ImClone, InterMune, Metamark Genetics, Grifols, ISTA Pharmaceuticals, Shire, Vertex and many more. Attendees have the opportunity to customize their congress by choosing between workshops, pre- and post-launch tracks and participating in interactive panel discussions. Session highlights include:

  • Product Commercialization Simulation from Candidate Selection through Launch
  • Reimbursement Strategies to Ensure Favorable Coverage, Coding and Payment Decisions
  • The Emergence of Personalized Medicine
  • Global Rollout
  • Brand Commercialization in a Crowded Therapeutic Marketplace
  • Building Specialty Launch Teams
  • Re-Positioning Products Post-Launch
  • KOL Engagement to Optimize Commercialization Efforts

CMAC 2011 is the industry's only opportunity to participate in an executive-level exchange addressing the overarching product development and launch environment, as well as tactical approaches for pricing, reimbursement, product launch, commercial strategy, branding, managed care and HEOR. For more information on the conference or to view the entire agenda, please visit http://www.cbinet.com/cmac2011.  

About CBI:

CBI, a subsidiary of Advans
'/>"/>

SOURCE CBI
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Independent Monitoring Board Recommends Completion of Accrual to Genasense(R) Phase 3 AGENDA Trial in Advanced Melanoma
2. TechConnect World Publishes Conference Agenda Featuring More than 2,700 Presentations Addressing Nano, Bio and Clean Technologies
3. American Society of Anesthesiologists Primary Agenda Displayed Says Dr. Barry Friedberg of Cosmetic Surgery Anesthesia
4. CBI Announces the Agenda for Their West Coast Forum on Clinical Supply Chain Management
5. CBI Announces the Agenda for Their 6th Annual Pharmaceutical/Biotech Accounting and Reporting Congress
6. 'Biopolymers Symposium 2010' Agenda Announced
7. Full Agenda Announced for CBIs Commercialization and Market Access Congress (CMAC 2010)
8. 2008 National Ergonomics Conference Schedule Announced, Features Four New Tracks of Programming and Focus on Corporate Sustainability and Productivity; Most Product Debuts in Expos 14-Year History
9. 2008 R&D Innovator of the Year & Scientist of the Year Finalists Announced
10. First Annual Arizona Biotech Day Announced for October 23rd 2008
11. Presenters Announced For MichBio Expos Emerging Business Showcase
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... Feb. 26, 2015 DuPont Executive Vice President ... by key research advancements and product launches across the ... of America Merrill Lynch 2015 Global Agriculture Conference. ... building grain supplies the last two years, long-term demand ... pace of the last decade, when demand for corn ...
(Date:2/26/2015)... -- BioEnterprise today announced that Northeast Ohio ... billion in growth funding during the past 13 years.  ... state – including the Ohio Third Frontier - and ... been raised in the past five years. ... BioEnterprise Midwest Healthcare Growth Capital  Report.   ...
(Date:2/26/2015)... (PRWEB) February 26, 2015 According to ... ÔÇťAgricultural Biotechnology Market For Transgenic Crops (Corn, Soybean, Cotton ... Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 ... USD 15,300 million in 2012 and is expected to ... CAGR of 9.5% from 2013 to 2019. , ...
(Date:2/26/2015)... Feb. 26, 2015  Epic Sciences announced today that ... present at the 35th Annual Cowen and Company Health ... the MIT Room, 3rd Floor. The conference will be ... Mass. Epic is developing diagnostic tests of ... and proteomic changes that occur during the course of ...
Breaking Biology Technology:DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 2DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 3DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 4DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 5More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 2More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 3More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 4Global Agricultural Biotechnology Market is Expected to Reach USD 28,694.1 Million in 2019 : Transparency Market Research 2Global Agricultural Biotechnology Market is Expected to Reach USD 28,694.1 Million in 2019 : Transparency Market Research 3Epic Sciences to Present at 35th Annual Cowen and Company Health Care Conference 2
... November 6 AIM-quoted drug discovery,company Verona Pharma ... the planned development of its anti-asthma and hay ... compound, RPL554, is now entering a,second 28-day experimental ... demonstrate safety, before moving onto the proof of ...
... VALAIS, Switzerland, Nov. 5 ,Lantibio, Inc. and TRB Chemedica ... subsidiary of Alcon, Inc. (NYSE: ACL ) for ... Syndrome product. The,product consists of a TRB patented formulation ... US under an IND by a,subsidiary of Lantibio. An ...
... Nov. 5 Palatin Technologies,Inc. (Amex: PTN ) ... on November 9, 2007 before the open of the ... teleconference and live audio webcast,hosted by Palatin,s executive management ... the results of operations in greater detail and provide,an ...
Cached Biology Technology:AIM-Quoted Verona Pharma Progresses Anti-Asthma Drug Studies 2Lantibio and TRB Chemedica Announce Licensing Agreement with Alcon for US Development and Marketing of Dry Eye Drug 2Lantibio and TRB Chemedica Announce Licensing Agreement with Alcon for US Development and Marketing of Dry Eye Drug 3Lantibio and TRB Chemedica Announce Licensing Agreement with Alcon for US Development and Marketing of Dry Eye Drug 4Palatin Technologies to Report Fiscal Year 2008 First Quarter Results; Teleconference and Webcast on November 9, 2007 2
(Date:2/5/2015)... , Feb. 3, 2015 Despite ... demand from industries such as consumer electronics, automotive, ... for surface mount technology (SMT) screen printers. Innovations ... automatic control will push the adoption curve up. ... remain steady as glue dispensers are indispensable in ...
(Date:1/22/2015)... 13, 2015 Technology Showcase, Hall E -   EyeLock ... today announced it will showcase its EyeLock ID technology integrated ... Department of Energy,s Oak Ridge National Laboratory (ORNL) ... EyeLock,s iris identity authentication technology is being used to validate ...
(Date:1/22/2015)... 21, 2015  Analyst Report Issued by Small Cap IR. In ... that planet-wide, transactions at merchants on the leading payment cards ... of credit, debit, and prepaid cards reached 6.54 billion.  Eight ... fraudulent card usage in 2012, and credit and debit card ...
Breaking Biology News(10 mins):End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 2End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 3EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2
... Stanley, Inc. (NYSE:,SXE), a leading provider of systems ... announced today that it has entered into a,definitive ... intelligence operations and information technology services,company. The purchase ... to certain working capital and other adjustments as ...
... Calif.) Michael Gazzaniga, professor of psychology at UC ... the Study of the Mind, has received the Humboldt ... "Professor Gazzaniga is a true pioneer in reaching ... the relationship between mind and brain," said UCSB Chancellor ...
... Dozens of instruments to be deployed on the Oak ... provide valuable information related to climate change, biodiversity and ... Walker Branch Watershed and other portions of the ... National Ecological Observatory Network, a multi-decade continental-scale research platform ...
Cached Biology News:Stanley to Acquire Oberon Associates 2Stanley to Acquire Oberon Associates 3Stanley to Acquire Oberon Associates 4Neuroscientist Michael Gazzaniga awarded Humboldt Prize 2Oak Ridge pegged for national ecological network 2
... Incubator is a compact benchtop and ... microprocessor controller with a large display ... agitation speed. Air circulation inside to ... Temperature can be easily calibrated from ...
... a cocktail of 3 siRNAs specifically targeted ... most popular product. The siTrio reagent guarantees ... your target gene when used under standard ... confirmation of optimal transfection with one of ...
... Incubator is a compact benchtop and ... microprocessor controller with a large display ... agitation speed. Air circulation inside to ... Temperature can be easily calibrated from ...
Tan solid. A glycoside used to permeabilize cellular membranes. Exhibits hemolytic activity. Contaminants: ash: ≤10%. Soluble in H 2 O. pH 4.4 - 4.6. RTECS VQ1400000, CAS 8047-15-2. References:...
Biology Products: